SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

2 hedge funds and large institutions have $4.77K invested in Seelos Therapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$564

Top Sellers

1
-$40.6K
2
-$31.8K
3
-$2.54K
4
BlackRock
BlackRock
New York
-$1.33K
5
TRCT
Tower Research Capital (TRC)
New York
-$357
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
AdvisorShares Investments
Maryland
$4.77K
VWWMG
2
Vermillion & White Wealth Management Group
Pennsylvania
$2
MWM
3
Modera Wealth Management
New Jersey
–
UBS Group
4
UBS Group
Switzerland
–
Morgan Stanley
5
Morgan Stanley
New York
–
BlackRock
6
BlackRock
New York
–
TRCT
7
Tower Research Capital (TRC)
New York
–
Bank of America
8
Bank of America
North Carolina
–
JPMorgan Chase & Co
9
JPMorgan Chase & Co
New York
–
Group One Trading
10
Group One Trading
Illinois
–
CA
11
Crewe Advisors
Utah
–
Wells Fargo
12
Wells Fargo
California
–
NFSG
13
Newbridge Financial Services Group
Florida
–